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Introduction
The belief that increased height is a healthful by-product of our 
Western lifestyle and nutrition is widely held.1–4 This belief is based 
on the large increase in life expectancy over the past 150 years. 
However, during the 20th century the increase in longevity has 
paralleled an explosive growth in chronic diseases.2,5,6 The fact that 
people are living longer is the most obvious explanation for this 
trend. However, India, as well as other countries, has experienced 
an epidemic of coronary heart disease (CHD) and type 2 diabetes 
among the young and middle-aged segments of the population.7 
In addition, before the 1970s, over 65% of the world’s elderly 
people lived in developing countries8 when cardiovascular disease 
(CVD) and diabetes were rare. The elderly in these countries died 
from essentially the same causes as young people,9 for example 
malnutrition, trauma, infections and lack of medical care.
Over the past few decades, more than 100 researchers (Samaras, 
unpublished) have questioned whether higher birth weight, rapid 
growth, early sexual maturation and increased height pose health 
risks.1, 2,10–12 Holzenberger13 also observed that improvements in 
living conditions over the past 150 years have masked the negative 
effects of greater growth and height.
Body height and weight have a harmful impact on many 
physiological parameters.14 In addition, a world population of taller, 
leaner humans weighing 25 kg more than previous generations 
requires a huge increase in energy, resources, water and food. As 
a result, the environment is negatively impacted, and pollution and 
global warming threaten human survival. All these issues cannot be 
explored here and are discussed elsewhere.14 The focus of this paper 
is to review the impact of increasing height on chronic diseases and 
longevity.
Increasing height and weight and the future impact of 
genetic engineering
The world trend towards increasing height is viewed positively 
by most growth experts.3,4 The reasons for this trend have been 
increased energy and protein intake and reduced childhood illness. 
However, social bias and increasing life expectancy have propagated 
the belief that greater height is desirable without a systematic 
evaluation of the ramifications of increasing body size (height and 
weight are strongly correlated). 
Should we promote a population of 185 cm males and 173 cm 
women as found in the Netherlands? Or would some other height 
be better? Based on current public bias favouring tallness, it would 
appear that if young males averaged 185 cm in 2020, parents 
would probably favour having their children 2 to 4 cm taller than 
average, if they had a choice. Advances in genetic engineering offer 
a mechanism for increasing the average height of future generations 
through genetic manipulation. Hopefully, growth experts and social 
scientists can recognise the hazards of this scenario and prevent 
an undesirable increase in human body size. Some may argue that 
changes in nutrition to limit growth trends would interfere with 
nature. However, contemporary eating habits are far from ideal and 
involve processed and domestic animal foods that were not available 
during most of human history.
The relation of higher birth weight and rapid growth 
to obesity and future illness
Higher birth weight has generally been viewed as beneficial to 
childhood and adult health3,15 for example, many studies have 
observed that lighter babies who grow rapidly have higher perinatal 
mortality and increased adult illness.15,16 Wells17 noted that small 
infants and children exposed to richer nutrition after a more 
restricted fetal diet also experience harmful health consequences in 
adulthood. However, a number of recent studies indicate that higher 
Abstract
Findings supporting the counter-intuitive thesis that smaller body size promotes greater health and longevity are reviewed. In addition, 
the risks of promoting further growth through genetic manipulation are explored in relation to chronic disease and longevity. Supporting 
examples from animal research are also covered. The biological mechanisms that relate to height and longevity conclude the review. 
 S Afr J Clin Nutr 2009;22(4):171-176
Invited Review: Are 20th-century recommendations for growth and height correct? 
172
Invited Review: Are 20th-century recommendations for growth and height correct? 
2009;22(4)S Afr J Clin Nutr
birth weight is not necessary for low perinatal mortality.15,18,19 In Table 
I the all-cause and CHD adult mortality of people born during the 
Dutch famine is shown.20 While poor fetal nutrition is likely to have a 
negative health impact, exposure to famine during late gestation had 
the lowest birth weight and the lowest all-cause mortality.
Rapid growth is also viewed as reflecting good nutrition, and slow 
growth is viewed as a failure to thrive.2,3,4 Unfortunately, these views 
have a number of problems associated with them; for example, 
DeHeeger,11 Heude21 and Freedman22 have observed that the trend 
in rapid growth and increasing height has paralleled the increase in 
the obesity epidemic and has promoted greater chronic disease in 
adulthood. Mangel and Munch23 also reported that catch-up growth 
is related to increased mortality and reduced longevity. These 
negative trends have been counteracted by improved sanitation and 
medical care, which have avoided sharp reductions in life expectancy 
although the elderly suffer from many chronic ailments.
Studies in recent years have also shown that higher birth weight 
promotes cancer, type 1 diabetes and obesity.24–27 In addition, 
Sorensen28 found that it did not take much of an increase in birth 
weight to go from normal to abnormal adult weight as shown in 
Table II. 
Substantial findings indicate that a rapid increase in height or weight 
in childhood promotes adult obesity.24,26,29 Freedman22 also found 
that tall children were five times more likely to become obese adults 
compared to shorter than average children. Recently, Jacobsen30 
found that women who reached puberty before 11 years of age had 
a 20% higher all-cause mortality compared to those who reached 
puberty at 17. Soltesz et al 27 also found that type 1 diabetes was 
related to rapid growth. They reported that increases in birth weight 
and childhood height and weight correlated with increasing risk of 
type 1 diabetes. 
Cohen and Strum31 observed that in the recent past, shorter men and 
women had substantially greater BMIs when compared with taller 
men and women. However, over the past 40 years, this situation 
appears to have changed and today taller people are experiencing 
rising BMIs at a faster rate than seen in shorter people. In the past, 
taller people were often leaner because lifestyle and standardised 
food portions provided a relatively lower amount of energy for their 
body size; for example, a glass of milk or a sandwich provides the 
same amount of energy to both tall and short people. In addition, 
taller people expended more energy in moving their larger bodies 
and were more active years ago.
How body size relates to chronic disease 
Many epidemiological studies find that taller people have less CVD.32 
However, a number of studies also find little difference or a positive 
correlation with height.29,32,33 Since early in the 20th century, many 
studies have found that people in southern Europe and developing 
countries had very little or no CHD and that these people were 
substantially shorter and leaner than most Western populations (see 
Table I: Decreasing birth weight and mortality from the Dutch famine studya 
Birth weight (g) Famine status All-cause mortalityb
CHD 
mortalityb
3 452 (highest) Early exposure 6.5% 1.1%
3 418 Conceived after famine 5.9% 1.2%
3 370 Born before famine 9.1% 1.9%
3 215 Mid exposure 6.0% 1.2%
3 135 (lowest) Late exposure 4.4% 1.2%
a One thousand nine hundred and ninety-one people tracked to age 57. Future follow-up findings may 
change results
b Percentage of deaths for each cohort
Table II: Average birth weight in relation to male adult weight status




Table III: Short (≤ 165 cm) nondeveloped populations with little or no CVDa
Population Population
Congo Pygmies Okinawa
Papua New Guinea Vilcabambia (Ecuador)
South African rural blacks Cook Islands
Tarahumara (Mexico) Crete (males < 170 cm in1960s)




Solomon Islands Kalahari Bushmen
Yanomamo (South America) Kitava (Trobriand Islands)
a Many of these populations are adopting Western nutrition and lifestyle patterns and CVD has increased 
in recent years
Table IV: Short vs tall male CHD mortality in developed populationsa,b
Short population CHD mortality Tall population CHD mortality 
Japan 35.7 The Netherlands 97.6
Hong Kong 47.6 Germany 125.8
France 49.1 Norway 128.2
Portugal 65.1 Denmark 129.6
Spain 65.5 Sweden 134.4
Italy 74.0 Finland 182.1
Average mortality 56.2/100K/year 132.9/100K/year
a Short average ~ 170 cm and tall ~ 179 cm 
b Mortality deaths/K = 100 000/year for 1995–1998
Table V: CHD mortality by height in California based on 123 164 male deaths
Ethnic group in order of decreasing 
height
Male age-standardised mortality 







a African-American and white males about the same height
b Chinese and Japanese males about the same height
c Female mortality similar to that of males; stroke declined at a slower rate
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Table III).34 Most of the males averaged less than 165 cm. In addition, 
examination of 50 developed countries found that in the six countries 
with the lowest CHD mortality people were relatively short (see Table 
IV).34 Table V also shows confirmatory data from California based on 
262 333 male and female deaths. 
The proponents of the benefits of modern growth trends argue 
that the developed world cannot be compared to the developing 
world because different factors are involved and decreased height 
in developing nations is not the cause of their low CVD. Certainly, 
lifestyle, diet, stress levels, BMI, medical care and economics all play 
a role. However, a number of studies indicate that the 20th-century 
explosive growth of CVD and other Western diseases was mainly due 
to changes in nutrition,5,6,12 which led to greater body size.12 These 
findings contradict the proposition that abundant protein and energy, 
along with greater height, promote superior health.
A recent report by the World Cancer Research Fund 6 notes that 
many chronic diseases common today were rare, even in old age, 
before the Industrial Revolution. The report also notes that traditional 
societies that follow a plant-based diet are also relatively free of 
CVD, diabetes and certain cancers.6,35,36 Yet, these populations are 
short and lean.
Ethnicity does not appear to play a role in the low CVD of developing 
populations.37 Activity levels can be a factor, but some populations 
indulge in heavy physical activity (for example Papua New Guinea) 
while others (Kitava) are not much different in activity terms from 
Western nations.38 It should also be borne in mind that dietary 
practices in developing populations are substantially different in 
that they focus on plant-based diets and are relatively low in energy 
intake. These dietary practices generally produce shorter height, low 
weight and low CVD. Of course, the developing world suffers from 
much poorer medical care and malnutrition, which affects short- 
and long-term health; for example, most deaths in rural parts of the 
developing world are due to the same causes as in the young and 
elderly.9
The question arises, is it diet or body size that sharply reduces CVD in 
developing populations? Certainly, higher weight or BMI is related to 
increased CVD for humans6; for example, a study of football players 
found that the largest players had six times the death rate from heart 
disease as the smallest players.39 Furthermore, animal studies also 
find that both energy restriction and smaller body size independently 
promote longevity,40 which cannot be readily attained unless CVD 
is also low. Rollo41 also reports that smaller body size is more often 
related to longevity than is energy restriction. 
How height affects longevity
Few epidemiological studies that found that tall people live longer 
actually measured longevity; for example, the average age at death 
for the entire cohort vs. height was rarely examined. However, 
Waaler’s42 study tracked mortality over a wide range of ages. He 
found that male mortality declined with increasing height for 
ages below 70 years. However, men over 183 cm experienced a 
substantial increase in mortality from 70 to 85 years and a slight 
decrease occurred for those aged 86–94 years. Since most people 
die between the ages of 70 and 85, this can be a more important 
mortality period than death rates at younger or older ages.
In contrast, studies finding that shorter people live longer than tall 
ones have involved longevity studies; for example, in these studies 
deceased cohorts were examined to determine the average ages 
at death based on height. Over 20 studies have been found that 
examine longevity or all-cause mortality rates for elderly populations. 
A summary of 12 studies is shown in Table VI.34 Many of these 
studies have shown a 0.5-year drop in average age at death for 
each centimetre (cm) increase in height. 
In addition, the greater life expectancy of women applies to almost 
all populations in the world. American males are 9% taller and have 
a 9% lower life expectancy.34 When American men and women were 
compared, male life expectancy dropped by 0.5 years/cm. This 
pattern was also reported for five different groupings of men and 
women in 2003.43 Miller44 found that males of the same height as 
females lived somewhat longer. Another study found that dwarf male 
mice lived 50% longer than their normal size female siblings.45
The largest study to date tracked the survival of 1.3 million Spanish 
males from youth to end of life over a 70-year tracking period.13 
The researchers found a correlation coefficient (r) of r = –0.6 
between height and longevity (p < 0.001). Heights were based 
on military recruitment records and thus were not confounded by 
height shrinkage. The researchers also noted that other possible 
confounders did not affect the results. 
More recently, a Sardinian study found that shorter people lived 
longer.46 This study involved about 400 males and their heights were 
based on military records. A subsequent study confirmed the earlier 
findings (personal correspondence with Salaris, 2008). In addition, 
Poulain et al47 showed (see Table VII) that the prevalence of European 
centenarians increased with decreasing height. 
Table VI: Populations illustrating reduction in longevity with increasing height
Population
Slope (decrease in longevity 
per centimetre of height 
[years/cm])
Baseball players (males) –0.35
Celebrities, study 1 (males) –0.43
Celebrities, study 2 (males) –0.41
Elderly Swedes (males and females) –0.52
Former Finnish athletes (males) –0.49
Former football players (males) –0.81
Former Harvard athletes (males) –0.70
French (19th-century males and females) –0.51
Males vs females (average based on  
21 European countries)
–0.47
Ohio general population (males and females) –0.47
US males vs females –0.52
US veterans (males) –0.47
Average slope –0.51years/cm
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A recent evaluation of life expectancy by population showed that the 
top populations where life expectancy is concerned were relatively 
short in comparison to the tallest populations in Western Europe (see 
Table VIII).34 The shorter populations had an average rank of 3 vs 29 
for the tallest populations.
Centenarians are generally small.34,48 The highest percentages of 
centenarians are found in Okinawa and Sardinia; both populations 
are short people by European standards. The Okinawan centenarian 
males average 148 cm (152 cm adjusted for shrinkage) and the 
Sardinians 160 cm. George Francis recently died at 114 years and 
weighed ~ 45 kg even in his youth.49 He was exempt from military 
service during World War I because he was too short. However, there 
are exceptions. Gavrilov and Gavrilov50 found that average-height 
World War I men reached 100 years of age more often than short 
men. Tall men did better than short but not as well as average-height 
men. Perhaps the short men, born between 1880 and 1900, were the 
product of poverty and illness common to urban areas. In contrast, 
rural men had better nutrition, a healthier environment, grew taller 
and lived longer.
Since height is related to nutrition, especially protein intake and total 
energy, it is interesting to note that a World Cancer Research Fund 
report published found that restricting energy intake postponed the 
onset of many age-related chronic diseases.51 It is not surprising 
that this report urges the public to consume minimal animal 
protein and lower the intake of high-energy foods. Conflicts with 
traditional epidemiological findings are probably due to a number of 
confounders, summarised in Table IX.4,32,52–55 For example, the impact 
of socioeconomic status is illustrated by Osika’s56 study that found 
that higher income tall people had a lower risk of heart disease than 
higher income short people. However, when the researchers looked 
at low-income people, they found that tall people had a 40% higher 
risk than short people. Another example involves the United States 
where taller upper class people had a higher risk of CVD compared 
to shorter working class people in the early part of the 20th century, 
but then the pattern reversed after the 1970s.57 Since relative 
height between the classes did not reverse, CVD increased due to a 
combination of factors, for example greater weight, excess nutrition 
and lifestyle.
Supporting data from animals and trees
Animal studies confirm previously described human longevity 
findings related to height and body size.41,58,59 For example, giant 
mice created through genetic manipulations also have much shorter 
lives.41 Bartke58 also found that smaller mice and rats live substantially 
longer than larger versions of their species. Several studies have 
found that smaller and shorter dog breeds live longer than larger 
ones.59,60 Smaller horses also live longer than larger ones.59
Great Basin bristlecone pines are the world’s longest living trees and 
average only 15 to 30 feet. These trees also grow very slowly. In 
addition, Eastern white cedar trees growing along the cliffs between 
Table VII: Comparative prevalence of centenarians in Europe
Country/region in order of increasing height
Number of centenarians 







Table VIII: Life expectancy ranking for developed populations (both sexes)
Rank Shorter states
Life expectancy at birth 
(years)
1 Andorra (between France and Spain) 83.52
2 Macao (64 km west of Hong Kong) 82.27
3 Japan 82.02
4 San Marino (central Italy) 81.80
4 Singapore 81.80
6 Hong Kong 81.68
Tallest states (Western Europe)
7 Sweden 80.63
20 Norway 79.67




Table IX: Confounders that may explain conflicting height vs CVD findings
•	 Low-birth	weight	children	experience	catch-up	growth,	remain	
shorter but also have higher risk of chronic diseases.4,15,52,53 
•	 Childhood	illness	can	cause	reduced	growth	and	higher	mortality	in	
adulthood. However, this decreased height is not the cause of future 
illness.
•	 A	comparison	is	made	between	tall	and	short	people	who	are	not	of	
the same proportions; for example, tall, lean people are compared 
to short, stocky people. 
•	 Shorter	people	have	more	abdominal	obesity	and	the	latter	
increases their CVD risk.53
•	 Taller	people	are	from	higher	socioeconomic	classes4,10 and have 
a lower mortality risk due to improved living conditions and higher 
education.
•	 Failure	to	adjust	for	all	three	life	phases.	Early,	middle	and	elderly	
life phases all play a role in mortality rates. Failure to adjust for 
these differences can lead to study errors.54
•	 Adjustment	for	various	risk	factors	is	a	crude	and	inexact	process	
that can lead to erroneous results.55 This adjustment generally 
reduces the mortality of shorter people.
•	 If	five-year	cohorts	are	used,	shorter	people	in	a	given	age	cohort	
tend to fall at the higher end of the age range while taller people 
fall closer to the younger age of the cohort. As a result an error 
of up to 40% can be made in mortality rates due to this age 
difference; for example, for the age range of 60 to 64 years, tall 
people may fall near 60 years and short people near 64 years.
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Canada and the US grow extremely slowly and have final heights 
that are much lower than those of cedars growing on flat terrain. 
These stunted trees also live much longer than normal-growing 
white cedars.61
Biological changes due to increasing height
There are a number of biological mechanisms that support the 
‘smaller lives longer’ thesis. An important one involves cellular 
proliferation. A larger body requires more cell duplications from birth 
to final adult height. In addition, maintenance of these cells during 
a lifetime uses up even more of the body’s ability to create healthy 
cells in place of defective or cancerous ones. Thus, growth and 
maintenance processes reduce the potential cell doublings in old age 
for taller people. Empirical findings indicate that elderly taller people 
have a lower potential for cell duplications.62 Women also have more 
potential cell duplications compared to taller men, although they 
start life with the same potential as indicated by telomere lengths.
Several other mechanisms exist to support increased longevity of 
shorter and smaller bodies. These include reduced DNA damage, 
smaller left ventricular mass, lower exposure to viruses and 
parasites, and relatively larger organs (see Table X).30,34,63–71 Energy 
restriction has been found to be the most effective approach for 
extending longevity.58,59,72,73 Thus, a diet that slows growth and 
avoids excessive body size is more likely to improve longevity, as 
was found in Hawaii and Okinawa.73
Conclusions
Modern developments, such as improvements in working 
environments and medical care, may have masked the negative 
effects of excessive nutrition and increased height and weight.13,59 
However, human and animal findings indicate that we can improve 
human health by emphasising plant-based diets,6,12 reducing energy 
intake, slowing growth and attaining shorter height and lower 
weight.10,34,72
The findings in this paper are based on a wide variety of investigations, 
including prospective, cross-sectional, descriptive and ecological 
studies. The populations in these studies vary from a few hundred to 
millions of people, and a variety of ethnic groups and geographical 
areas are included. The timeline goes back to the 19th century, and 
historical data5,6,34 show that Western diseases, the primary cause of 
later-life mortality, correlate with changes in nutrition, lifestyle and 
increasing body size. 
While substantial evidence supports the health and longevity 
advantage of low energy, protein and meat intake6,12,73 and smaller 
height and body weight, the role of body height per se represents a 
relatively small slice of the longevity pie (r2 = 0.13 or 13%). Living 
standards, medical care, stress, smoking, diet, BMI and satisfaction 
with one’s life have a greater total impact. That is why some 
centenarians are not short and many tall people reach advanced ages; 
for example, John Kenneth Galbraith (203 cm) lived to 98 years of 
age. However, promoting widespread increases in height and weight 
through overnutrition will have a major impact on future health costs 
that could adversely affect most economies of the world.
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